A detailed history of Diamond Hill Capital Management Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Diamond Hill Capital Management Inc holds 76,630 shares of QURE stock, worth $436,791. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,630
Previous 76,630 -0.0%
Holding current value
$436,791
Previous $343,000 9.91%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$4.82 - $6.93 $108,184 - $155,543
22,445 Added 41.42%
76,630 $398,000
Q4 2023

Feb 05, 2024

BUY
$5.63 - $8.27 $164,829 - $242,120
29,277 Added 117.54%
54,185 $366,000
Q3 2023

Nov 02, 2023

BUY
$6.71 - $11.83 $167,132 - $294,661
24,908 New
24,908 $167,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $266M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Diamond Hill Capital Management Inc Portfolio

Follow Diamond Hill Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diamond Hill Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Diamond Hill Capital Management Inc with notifications on news.